These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 27060945)

  • 21. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
    Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
    Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ameliorative effect of alendronate against intracerebroventricular streptozotocin induced alteration in neurobehavioral, neuroinflammation and biochemical parameters with emphasis on Aβ and BACE-1.
    Zameer S; Kaundal M; Vohora D; Ali J; Kalam Najmi A; Akhtar M
    Neurotoxicology; 2019 Jan; 70():122-134. PubMed ID: 30481507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The n-terminal 5-MER peptide analogue P165 of amyloid precursor protein exerts protective effects on SH-SY5Y cells and rat hippocampus neuronal synapses.
    Wang P; Jiang S; Cui Y; Yue Z; Su C; Sun J; Sheng S; Tian J
    Neuroscience; 2011 Jan; 173():169-78. PubMed ID: 21055450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of curcumin nanoparticles on streptozotocin-induced male Wistar rat model of Alzheimer's disease.
    Noor NA; Hosny EN; Khadrawy YA; Mourad IM; Othman AI; Aboul Ezz HS; Mohammed HS
    Metab Brain Dis; 2022 Feb; 37(2):343-357. PubMed ID: 35048324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.
    Yu CJ; Liu W; Chen HY; Wang L; Zhang ZR
    Cell Biochem Funct; 2014 Oct; 32(7):590-6. PubMed ID: 25230339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.
    Ravelli KG; Rosário BD; Camarini R; Hernandes MS; Britto LR
    Neurotox Res; 2017 Apr; 31(3):327-333. PubMed ID: 27913964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer's disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance.
    Akhtar A; Dhaliwal J; Sah SP
    Psychopharmacology (Berl); 2021 Jul; 238(7):1991-2009. PubMed ID: 33774703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
    Shi L; Zhang Z; Li L; Hölscher C
    Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats.
    Ishrat T; Khan MB; Hoda MN; Yousuf S; Ahmad M; Ansari MA; Ahmad AS; Islam F
    Behav Brain Res; 2006 Jul; 171(1):9-16. PubMed ID: 16621054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of D-galactose/AlCl3 inducing rats model of Alzheimer's disease.
    Li H; Kang T; Qi B; Kong L; Jiao Y; Cao Y; Zhang J; Yang J
    J Ethnopharmacol; 2016 Feb; 179():162-9. PubMed ID: 26721223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.
    Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT
    Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of memantine on expression of Bace1-as and Bace1 genes in STZ-induced Alzheimeric rats.
    Azadfar P; Noormohammadi Z; Noroozian M; Eidi A; Mortazavi P
    Mol Biol Rep; 2020 Aug; 47(8):5737-5745. PubMed ID: 32648077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats.
    Solmaz V; Çınar BP; Yiğittürk G; Çavuşoğlu T; Taşkıran D; Erbaş O
    Eur J Pharmacol; 2015 Oct; 765():482-7. PubMed ID: 26386291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
    Ejaz Ahmed M; Khan MM; Javed H; Vaibhav K; Khan A; Tabassum R; Ashafaq M; Islam F; Safhi MM; Islam F
    Neurochem Int; 2013 Mar; 62(4):492-501. PubMed ID: 23411413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A New Approach to Model Sporadic Alzheimer's Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice.
    Kelliny S; Lin L; Deng I; Xiong J; Zhou F; Al-Hawwas M; Bobrovskaya L; Zhou XF
    Mol Neurobiol; 2021 Aug; 58(8):3692-3711. PubMed ID: 33797693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic effects of sporoderm-removed Ganoderma lucidum spores in a rat model of streptozotocin-induced sporadic Alzheimer's disease.
    Zhao HL; Cui SY; Qin Y; Liu YT; Cui XY; Hu X; Kurban N; Li MY; Li ZH; Xu J; Zhang YH
    J Ethnopharmacol; 2021 Apr; 269():113725. PubMed ID: 33352241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD.
    Li C; Liu W; Li X; Zhang Z; Qi H; Liu S; Yan N; Xing Y; Hölscher C; Wang Z
    Brain Behav; 2020 Mar; 10(3):e01505. PubMed ID: 31960630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of acute lipopolysaccharide-induced inflammation in intracerebroventricular-streptozotocin injected rats.
    Murtishaw AS; Heaney CF; Bolton MM; Sabbagh JJ; Langhardt MA; Kinney JW
    Neuropharmacology; 2016 Feb; 101():110-22. PubMed ID: 26327677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease.
    Kosaraju J; Gali CC; Khatwal RB; Dubala A; Chinni S; Holsinger RM; Madhunapantula VS; Muthureddy Nataraj SK; Basavan D
    Neuropharmacology; 2013 Sep; 72():291-300. PubMed ID: 23603201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CART peptide activates the Nrf2/HO-1 antioxidant pathway and protects hippocampal neurons in a rat model of Alzheimer's disease.
    Jiao W; Wang Y; Kong L; Ou-Yang T; Meng Q; Fu Q; Hu Z
    Biochem Biophys Res Commun; 2018 Jul; 501(4):1016-1022. PubMed ID: 29777699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.